Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 4Melanoma 3Healthy Participants 2Carcinoma, Non-Small-Cell Lung 2Advanced Solid Tumor 2cMET-dysregulated Advanced Solid Tumors 1Solid Tumor, Adult 1Solid Tumor 1Prostatic Neoplasms 1Neoplasm Metastasis 1Drug-drug Interaction,SHR3680 1Breast Neoplasms 1Advanced Solid Malignancies 1Advanced Pancreatic Cancer 1

Interventions

pembrolizumab 3Cyclophosphamide 3fludarabine 2Rosuvastatin Calcium 2Radiotherapy 2Paclitaxel 2Ipilimumab 2Interleukin-2 2Carboplatin 2spartalizumab 1peposertib 1osimertinib 1niraparib 1neotil 1necitumumab 1mirdametinib 1apatinib 1amivantamab 1Valganciclovir 1Tomography, X-Ray Computed 1Rifampin 1Radiation 1Positron-Emission Tomography 1PankoMab-GEX 1Panitumumab 1Nivolumab 1Midazolam 1Metformin 1Magnetic Resonance Imaging 1MEK inhibitor I 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Solid Tumor, Adult × Digoxin × Clear all
NCT06348290 2024-04-04

Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects

Jemincare

Phase 1 Unknown
72 enrolled
Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡